Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy (Q34992390)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

5 August 2017

Long-term follow up Helicobacter Pylori reinfection rate after second-line treatment: bismuth-containing quadruple therapy versus moxifloxacin-based triple therapy (English)

1 reference

Europe PubMed Central

5 August 2017

Helicobacter pylori

0 references

1 reference

based on heuristic

inferred from title

2

object named as

Nayoung Kim

1 reference

Europe PubMed Central

5 August 2017

author name string

Min Soo Kim

1

1 reference

Europe PubMed Central

5 August 2017

Sung Eun Kim

3

1 reference

Europe PubMed Central

5 August 2017

Hyun Jin Jo

4

1 reference

Europe PubMed Central

5 August 2017

Cheol Min Shin

5

1 reference

Europe PubMed Central

5 August 2017

Young Soo Park

6

1 reference

Europe PubMed Central

5 August 2017

Dong Ho Lee

7

1 reference

Europe PubMed Central

5 August 2017

publication date

19 September 2013

1 reference

Europe PubMed Central

5 August 2017

BMC Gastroenterology

1 reference

Europe PubMed Central

5 August 2017

13

1 reference

Europe PubMed Central

5 August 2017

138

1 reference

Europe PubMed Central

5 August 2017

copyright license

Creative Commons Attribution 2.0 Generic

19 September 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

0 references

https://scigraph.springernature.com/pub.10.1186/1471-230x-13-138

0 references

Management of Helicobacter pylori infection--the Maastricht IV/ Florence Consensus Report

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Helicobacter pylori treatment in the era of increasing antibiotic resistance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Clinical practice. Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Bismuth-containing quadruple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate in Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Guidelines for the management of Helicobacter pylori infection in Japan: 2009 revised edition

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Second Asia-Pacific Consensus Guidelines for Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Review article: 'true' re-infection of Helicobacter pylori after successful eradication--worldwide annual rates, risk factors and clinical implications.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

American College of Gastroenterology guideline on the management of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

The recurrence of Helicobacter pylori infection: incidence and variables influencing it. A critical review.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Helicobacter pylori reinfection is common in Peruvian adults after antibiotic eradication therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Dental implications of Helicobacter pylori.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Role of partner's infection in reinfection after Helicobacter pylori eradication.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Gastric mucosal atrophy: interobserver consistency using new criteria for classification and grading.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Review article: natural history and epidemiology of Helicobacter pylori infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Direct evidence by DNA fingerprinting that endoscopic cross-infection of Helicobacter pylori is a cause of postendoscopic acute gastritis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

A practical approach to patients with refractory Helicobacter pylori infection, or who are re-infected after standard therapy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Recurrence of Helicobacter pylori infection after successful eradication: nature and possible causes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

8 July 2018

Diagnosis and treatment guidelines for Helicobacter pylori infection in Korea

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Long-term follow-up Helicobacter pylori reinfection rate and its associated factors in Korea

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Long-term outcomes after Helicobacter pylori eradication with second-line, bismuth-containing quadruple therapy in Korea.

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Recrudescence and reinfection with Helicobacter pylori after eradication therapy in Bangladeshi adults

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Recurrence of Helicobacter pylori infection and the long-term outcome of peptic ulcer after successful eradication in Japan

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Moxifloxacin-containing triple therapy as second-line treatment for Helicobacter pylori infection: effect of treatment duration and antibiotic resistance on the eradication rate

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Oral cavity as a potential source of gastric reinfection by Helicobacter pylori

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

Reinfection rate in children after successful Helicobacter pylori eradication

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

High rates of recurrence and of transient reinfections of Helicobacter pylori in a population with high prevalence of infection

1 reference

https://api.crossref.org/works/10.1186%2F1471-230X-13-138

21 January 2018

The trends of one-week first-line and second-line eradication therapy for Helicobacter pylori infection in Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

26 October 2018

Incidence of Helicobacter pylori recurrent infection and associated factors in Thailand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

26 October 2018

Seroprevalence of Helicobacter pylori in South Korea

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

26 October 2018

Helicobacter pylori reinfection after apparent eradication--the Ipswich experience.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3848835

26 October 2018

Case of intrafamilial Helicobacter pylori reinfection after successful eradication therapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/24050512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Long-term study of re-infection following successful eradication of Helicobacter pylori infection

1 reference

https://pubmed.ncbi.nlm.nih.gov/24050512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

[Inter-departmental differences in the eradication therapy for Helicobacter pylori infection: a single center study]

1 reference

https://pubmed.ncbi.nlm.nih.gov/24050512

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1186/1471-230X-13-138

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

1 reference

Europe PubMed Central

5 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34992390&oldid=1863969140"